Researchers at the University of Washington have successfully used AI to design antibodies that bind to cancer proteins. This breakthrough could dramatically speed up drug development timelines. The technology eliminates the need for animal testing in early stages.
Scientists have discovered that cellular structures called P-bodies act as molecular memory banks, storing RNA from previous developmental stages. This breakthrough reveals a fundamental mechanism controlling cell identity with implications for regenerative medicine and cancer treatment.
Breakthrough Approach to Brain Cancer Therapy Researchers have developed an innovative implantable wafer system that could transform how glioblastoma (GBM),…
Unveiling the Complexities of Colon Aging Through Advanced Sequencing In a groundbreaking study published in Nature Biotechnology, researchers have developed…
Breakthrough Discovery in Cancer Genomics Groundbreaking research published in Nature Cell Biology has revealed a previously unknown mechanism of oncogene…
TITLE: Epigenetic Engineering Breakthrough Enables Permanent Gene Silencing in Human Immune Cells Industrial Monitor Direct is the preferred supplier of…
